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B.sc. HONS. (RAND) AND A. SoLOMON, M.B., B.CH., DIP. MED., D.M.R.D. (RAND), Departments of Medicine and
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Industrial Research and the Johannesburg Hospital
Progressive systemic sclerosis (scleroderma) is a chronic
disease of unknown aetiology. It affects women more
frequently than men, and is classified with the collagen
disorders. The aetiology is obscure, but recent evidence
tends to suggest that auto-immune mechanisms are in-
volved.'
The most striking manifestations are cutaneous, but
other organs may be involved, notably the heart, lungs,
gastro-intestinal tract and the kidneys. The skin of the
hands shows the most characteristic changes and becomes
smooth, waxy, leathery and tight, so that it cannot be
lifted from the deeper structures (sclerodactyly). Painful,
indolent ulcers develop over the ends of the fingers. Ray-
naud's phenomenon is common. Calcium is frequently
deposited in affected areas. Hyperpigmentation, and occa-
sionally depigmentation, of affected areas occurs.
Atrophy of the tissues of the face gives it a 'pinched'
appearance. The myocardium may be primarily involved
by fibrosis, or secondarily to systemic or pulmonary hyper-
tension.:
Lung involvement was first described in 1891 by Finlay.'
Pathological changes were described by Matsui in 1924.'
The lungs may show diffuse fibrosis involving the alveolar
walls with obliteration of capillaries and alveolar spaces.
The fibrosis may involve the bronchial walls and peri-
bronchial tissues, leading to the formation of bronchiecta-
sis. Therc may be evidence of recurrent pulmonary
infections.
Involvement of the gastro-intestinal tract may lead to
dysphagia and malabsorption. Death from renal failure or
malignant hypertension is not infrequent. Muscle changes
similar to those seen in dermatomyositis and polymyositis
have been described.
Studies of the deranged lung function in cases of
scleroderma were first reported in 1949; and others have
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been published more recently."· This paper reports studies
of pulmonary function in 11 patients with scleroderma,
and correlates these findings with clinical, radiological,
electrocardiographic and pathological findings.
MATERIAL AND METHODS
Eleven White patients were studied, 7 females (aged 19 - 68
years; mean 44·2 years) and 4 males (aged 33 to 63 years;
mean 48 years). Of the 4 males, 2 were gold-miners.'"
A full history and examination, radiography of the chest
and electrocardiography were carried out in every case.
The extent of systemic involvement was assessed clinically
and by radiographic examination of the gastro-intestinal
and urinary tracts. Renal function was further assessed
biochemically. Biopsy of the skin was carried out in 9 of
the 11 patients. Pulmonary function studies were carried
out on every patient and included the following:
(a) Lung volumes and distribution of ventilation (Table
1).
(b) Mechanics of breathing (Table 11).
(c) Ventilation and oximetric studies during rest and
exercise (Table Ill).
Techniques and predicted values used have been described
in previous publications from this laboratory.n.n
In case 4 a thermocouple was introduced per rectum and
the patient performed a 5-minute exercise-load (200 kg.-m./
min.). Temperature readings were taken every 30 seconds
during and for 5 minutes after the exercise.
RESULTS
Clinical Assessment
,Table IV shows the symptoms and signs of the 11
patients.
The duration of symptoms varied between 1 and 26
years. Five of the patients were smokers. Cough was present
in 6 patients, of whom 5 produced sputum, but only 2
smokers gave a history of cough. Dyspnoea was present
TABLE I. SUBDNISIONS OF LUNG VOLUME AND LUNG CLEARANCE INDEX
VC FRC RV TLC
FRC/TLC RV/TLC LCl
Case No. Meas. % Meas. % Meas. % Meas. % x 100 x]OO litre/litre
litres pred. litres pred. litres pred. litres pred. FRC
Males
I 4·66 84 5·36 124 2·95 131 7·65 101 79 38 2·02
2 3·67 81 3·35 105 1·80 105 5·48 87 6t 32 \·70
3 3·34 80 1·91 58 1·0\ 46 4·35 67 44 23 3·94
4 3·65 91 5·14 142 3·46 157 7·\ t 115 72 49 \·85
Females
5 2·84 86 1·76 69 1·14 64 3-98 80 49 34 3·47
6 3·32 92 2·92 98 0·92 56 4·24 81 69 22 3-15
7 1·95 60 3·38 101 1·89 86 3·84 73 88 47 2·71
8 2'55 84 2·93 97 1·79 107 4·39 95 65 35 2·36
9 1·78 47 3·08 95 1·46 101 3·24 64 94 45 2·53
10 2·71 89 3'55 146 2·39 \76 5·09 116 70 47 5·57
11 2·38 91 2·53 96 1·49 97 3·93 96 64 38 4·06
vc = vital capacity; FRC = functional residual capacity; LCI = lung clearance index; RV = residual VOlume; TLC = total lung capacity; % pred. = percentage
of predlcted value; Meas. = measured.
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TABLE n. VENTlLb,TORY CAPACITY AND MECHANICS OF BREATHING
Non-elastic resistance
MVVF Compliance (cm. H.O/litre/sec.)
(litre/min.) MMF FEV, FEV, : (litre/cm. H 2O)
Case No. (litre/sec.) (litre/sec.) FVC Inspiration Expiration
Meas. % pred. meas. meas. % Rest Ex.
Rest Ex. Rest Ex.
Males
1 139 97 2·47 2·40 62 0·214 0·157 1·38 1·36 1·72 1·74
2 148 97 2-15 2-10 63 0·235 0·343 1·55 2·54 2·54 7·31
3 129 103 2-18 2·29 71 0'178 0·131 2·70 1·71 2·60 3-17
4 88 101 0·92 1·88 57
Females
5 65 62 1·42 1·88 71 0·115 0·120 3·45 4·13 5·65 5·06
6 98 91 1·65 2·06 67 0·118 0·101 4'18 2·40 6·12 3·60
7 80 69 0·42 0'54 50 0'097 0'093 2·02 1·94 3·32 4·07
8 107 121 4·40 1·70 93 0'103 0'099 1·98 2·69 3·72 3·63
9 89 88 2·96 1·53 95 0·363 0'149 2·08 1·29 3'73 4·74
10 109 109 2·68 2·11 88
11 72 112 1·71 1·61 79 0·114 0·120 2·06 1·69 5·33 6·26
MVVF = maximal voluntary ventilation (free); MMF = maximal mid-expiratory flow; Ex. = exercise; FEV, = forced expiratory volume in I second; FVC = forced
vital capacity.
TABLE m. VENTILATION, OXIMETRY, HEART AND RFSPIRATORY RATES DURING REST AND EXERCISE
Rest vent. Ex. vent. Heart rate Resp. rate Art. O.
Load Duration (litre/min.) (litre/min.) per min. per min. sat. %
Case No. kg.-m. (min.)
Imino Meas. Pred. Meas. Pred.* Rest Ex. Rest Ex. Rest Ex.
Males
1 200 5 17·4 10·4 53·1 31·2 92 132 28 48 94 92
2 300 5 7·7 10·2 22'5 30'5 72 120 12 16 93 90
3 150 5 14·5 10·9 37·0 32'7 84 112 36 46
4 200 5 13·3 11·0 32·7 33·0 52 100 24 36 93 89
Females
5 200 5 13·0 10·1 38·2 37·6 80 164 28 38 93 86
6 300 5 12·5 8·6 38·8 31·6 96 164 24 30 91 85
7 200 5 11·2 8·3 25·9 30·4 78 134 20 28 89 84
8 100 5 14'2 7·2 24'9 26·2 96 122 28 30 94 98
9 100 5 14·2 6·9 24·7 25·3 114 158 30 28 88 89
10 250 5 15·6 8·6 26·8 31·9 84 148 36 32 88 81
11 100 1 21·8 7·4 34·0 27-1 84 88 40 40 89 85
Vent. = ventilation; Ex. = exercise; Resp. = respiratory; Art. 0. sat. % = percentage arterial oxygen saturation; ·Predicted value for 300 kg.-m./min.
in 7 cases, and Raynaud's phenomenon in 8 cases. All the
patients except case 7 had sclerodactyly, but she had
involvement of the trunk and face. Dysphagia was present
in 4 patients, but only 2 had an abnormal barium swallow.
Six patients gave a history of previous pulmonary in-
fection. Persistent crepitations were present in 4 patients.
Four patients had been in congestive cardiac failure. Of
these 4, 2 had clinical pulmonary hypertension (cases 8
and 9) and 3 left ventricular enlargement (cases 5, 7 and
9). Case 1 had pulmonary hypertension without failure.
Two of the 3 patients with left ventricular enlargement
(cases 5 and 9) had systemic hypertension and both had
renal involvement. The third patient with left ventricular
enlargement (case 7) had had a previous myocardial infarc-
tion. Case 5 had evidence clinically of both disseminated
lupus erythematosis and dermatomyositis: LE cells were
present on 1 occasion and the skin and muscle biopsy
showed the presence of both dermatomyositis and sclero-
derma. Six of the patients had calcinosis, for which they
had received steroids and ethylene-diamine-tetra-acetic acid
without significant improvement. Ten of the 11 patients
had received steroids." Three patients were, or had been,
attending a peripheral vascular clinic for severe intermittent
claudication.
Radiology
Radiological assessment revealed 5 patients with normal
appearances of the lung parenchyma. In the group without
parenchymal abnormalities 4 patients had prominence of
the pulmonary artery segment and 3 of these had support-
ive clinical or electrocardiographic evidence of pulmonary
hypertension. Six patients showed lung abnormalities,
including classical sclerocystic honeycomb patterns, nodu-
lar changes, and broad-band basal infiltrations as well as
mixed lesions.
The bases tended to show the most marked changes, as
noted by other workers." In case 3, a miner, radiographs
were available from 1956, 1957, 1958 and 1964. There
were no changes in 1956 but by ApriL 1957 basal nodular
opacities were' apparent (Fig. 1). In 1958 the changes were
well established and by 1964 there was granular honey-
combing and the nodular changes were much more empha-
tic (Fig. 2).
Rib erosions'" were not detected in any of the radio-
graphs.
Pulmonary Function Studies
Details of the individual cases may be seen in Tables
I - Ill. All 11 patients had some disturbance of lung
function. The pattern of disturbance in the majority of
cases was of combined restriction and obstruction, and no
single case exhibited features of pure restriction, obstruc-
tion or ventilatory or diffusion defects.
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7 15 + + + Pneumoconiosis + + + +
130
Pulmonary hypertension- 80
2 15 + + + + +
140
+90
3 ? 20 + ? + + Pleural effusion -I- + ? ? ? +
140
? ? +90
4 2-!- 35 + Pleurisy + +
140
+90
5 6 + + + Bronchitis, pneumonia + + + + + +
180
Left ventricular hypertrophy -I· +105
6 13 + + + + + + +
120
70
7 5 + + + + + + + + +
180
Left ventricular hypertrophy, + +80 mitral incompetence
8 5 10 + + Pneumonia + + + + +
110 Pulmonary hypertension +- 80
186 Left vp.ntricular hypertrophy,
9 1 + + + + + + + 124 pulmonary hypertension, + +gallop rhythm
10 2 + + + 11070
11 26 20 + + + Pneumonia on 3 occa- + + + + 104
sions 60
+ = presence - = absence ? = information not available
Fig. 1. Chest radiograph of case 3, a gold-miner, taken in






Fig. 2. Chest radiograph of case 3 taken in 1964. Nodular
opacities in the bases are more extensive and are accom-
panied by granular honeycombing.
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All patients had vital capacIties below the predicted
value. Total lung capacity was reduced in 5 patients, indi-
cating the presence of restrictive lung disease. These same 5
cases had a raised lung clearance index, indicating uneven
intrapulmonary distribution of the inspired gas.
The tests of ventilatory capacity, such as the maximum
voluntary ventilation, maximal mid-expiratory flow-rate,
and the forced expiratory volume in I second, were not
very often or consistently disturbed. Only case 5 had
evidence of airway obstruction in all the tests. Compliance
was reduced in nearly all cases and the non-elastic
resistance increased in approximately half the patients, so
that the work of breathing was increased in most patients.
All except I patient had an increased minute volume at
rest and during standardized exercise. Nine patients had
a fall in arterial oxygen saturation during exercise. These
features are consistent with the alveolar-capillary block
syndrome, and suggest that diffusion defects contribute to
the hypoxaemia. Uneven distribution of ventilation also
would contribute to the hypoxaemia.
Case 2 hypoventilated at rest and during exercise, yet
his arterial oxygen saturation was not significantly reduced.
His oxygen consumption was 149 ml./min. (SI'PD). It
seems possible, therefore, that this patient had hypothyroid-
ism, but unfortunately no tests were done to confirm this.
Case 4 repeated the exercise test with measurements of
rectal temperature. Ventilation at rest was 11·9 litre / min.
and during a 200 kg.-m./min. exercise load, ventilation
rose to 34·9 litre/min. The temperature at rest was 37·3°C
and during the exercise it fell slightly to 36.9°. In the post-
exercise period it varied between 36·8 ° and 37°C, but at no
time did the temperature exceed the resting level.
Course
There were 6 deaths in the series, 4 females and 2 males.
Three of the 4 female deaths were directly attributable to
their scleroderma. Patient No. 7 died on the operating
table following a local anaesthetic for a cervical sympathec-
tomy, her condition at the time of operation being extreme-
ly grave. Operative intervention was due to gangrene of the
fingers. Patient No. 8 died severely cachectic, following
malabsorption, diarrhoea and vomiting, as well as cardiac
and renal failure. Patient No. 9 died in uraemia as a
result of chronic renal failure associated with gastro-in-
testinal haemorrhage. Patient No. 5 committed suicide
although at the time she was relatively well.
The 2 male deaths were No. 3, a miner, and No. 4.
The latter patient died in April 1967 of renal failure due
to scleroderma. He was first seen in April 1966 at the
Peripheral Vascular Clinic, with sclerodactyly and indolent
ulcers on the pulps of his fingers. Renal function studies
done at that time revealed no abnormalities and a creatinine
clearance of 118 ml. / min. He was admitted to hospital in
March 1967 with congestive cardiac failure. His blood
pressure had risen from normal to 160/110 mm.Hg and
blood urea had risen to 535 mg./ lOO ml. The potassium
level was 7·5 mg./ lOO rnI. and the electrocardiogram
showed right bundle-branch block with marked peaked
symmetrical T waves indicative of hyperpotassaemia. In
spite of peritoneal dialysis the patient died in renal failure.
A needle biopsy of his kidney showed the typical onion-
skin appearance of the arteries in scleroderma.
The postmortem examination of the lung revealed
fibrous pleural adhesions and marked centrilobular emphy-
sema without macroscopic evidence of interstitial fibrosis.
There was evidence of acute bronchopneumonia in both
upper and lower lobes (Fig. 3). Microscopically moderate
Fig. 3. Whole-lung section of case 4. Note centrilobular
emphysema and foci of consolidation in posterior region
of lower lobe and upper lobe. The pale triangular area
in the upper lobe is an artefact.
interstitial fibrosis was detected. Postmortem examinations
were performed on 3 other cases and revealed similar pul-
monary pathology.
DISCUSSION
The diagnosis of systemic sclerosis is not usually made
unless there is unequivocal skin involvement. However,
skin changes may be minimal in cases in which there is
significant visceral involvement. Bates and Christie" sug-
gest that the diagnosis should be considered in any patient
who presents with Raynaud's phenomenon and detectable
abnormalities of pulmonary function.
On clinical examination lung involvement was considered
to be present in only 4 of our I I cases. Seven patients had
abnormal electrocardiograms and 10 had abnormal chest
radiographs. No direct correlation between clinical, radio-
logical, electrocardiographic and pulmonary functional
assessments was detected.' Only 4 electrocardiograms
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showed probable evidence of right ventricular strain.
Although 2 of our cases had complete right bundle-
branch block, Escudero and McDevittlS did not find this
among 60 cases of scleroderma.
Pulmonary function tests detected abnormalities in all
11 patients. There is no uniform pattern, probably because
of the progressive nature of the disease and tl)e fact that
cases were studied in different stages of involvement with
varying location and extent of the disease process.'" A
restrictive pattern dominates the functional disturbance
and where obstruction is present its degree is- usually much
less marked than in cases of airway obstruction from other
causes.'· The alveolar capillary block syndrome, for which
evidence was present in a number of our cases (although
we did not make direct measurements of diffusing capacity),
has also been well described." The 1 patient who had
hypoventilation may have had systemic involvement of
the thyroid gland causing hypothyroidism, but unfortunate-
ly no definitive tests for this were carried out.
The presence of chronic cough and sputum in non-
smokers suggests that these symptoms may well be due to
bronchial involvement. The latter can also result in hyper-
inflation distal to areas of peribronchial fibrosis. Three of
our patients (cases 1, 4 and 10) were hyperinflated but
none of them had significant airway obstruction. This may
be explained by the possibility that the inflated areas
were very peripheral in the lung, beyond petibronchiolar
fibrosis. Peripheral bronchiolar narrowing would contribute
little to an increased airway resistance." Our series contain-
ed 3 non-smokers with chronic cough and pulmonary
function tests indicating raised non-elastic resistance and
uneven distribution of inspired air.
In case 4 an attempt was made to determine whether
the hyperventilation was due to an inability of the body
surface to lose heat because of the scleroderma. Rectal
temperatures were measured at rest, during exercise and
during recovery, but at no time did the rectal temperatures
rise above the resting level. Unfortunately the experiment
is not conclusive as it is possible that heat loss and tempera-
ture control were maintained by hyperventilation even if
heat loss through the skin had been less than normal.
None of our cases had significant involvement of the
skin of the thorax and we presume that lung function tests
were not significantly altered by this factor." Subclinical
hypertensive left ventricular failure in cases 5 and 9 may
have influenced the pulmonary function tests. The systemic
hypertension present in these 2 patients may have been
related to scleroderma lesions in the kidney confirmed at
postmortem examination in case 9. Case 4 developed both
systemic hypertension and scleroderma of the kidney a
year after his initial tests. Cases 1 and 3 were gold-miners
and both had been exposed to a dusty atmosphere for over
20 years and were cigarette-smokers. The lung function
tests revealed a combined pattern of restriction and
obstruction. Erasmus found a higher incidence of sclero-
derma among Witwatersrand gold-miners than in the
general population.'• An increased incidence of this disease
in miners has been confirmed."
A recent review of 98 unselected patients with sclero-
derma revealed that pulmonary disease tended to be
8
associated with skin involvement of the head and neck, with
oesophageal abnormality and with Raynaud's phenomenon,
but not with the duration of the disease."
SUMMARY
Pulmonary function in 7 females and 4 males with scleroderma
is reported and correlated with clinical, radiological, electro-
cardiographic and pathological findings.
Duration of symptoms, the commonest being dyspnoea and
Raynaud's phenomenon, varied from 1 to 26 years. The electro-
cardiogram and chest radiograph were abnormal in most cases.
Some disturbance of pulmonary function was detected in every
case, a pattern of combined restriction and obstruction being
common. Hyperventilation at rest and during standardized
exercise accompanied by a fall in arterial oxygen saturation
(the alveolar-capillary block syndrome) was very frequent.
There was no uniform pattern, probably because the disease is
progressive and cases were studied in different stages of involve-
ment.
Six patients died during the period of observation and the
modes of death are described.
We wish to express our thanks to Dr H. van Wyk, Superin-
tendent of the Johannesburg Hospital, for permission to publish
the case studies; Dr Y. Gentin for helping to initiate the study;
Dr G. K. Sluis-Cremer, Director of the Miners' Medical Bureau,
for the case records of the miners; and Drs I. Prinsloo, C.
Abraharns and J. Notman for the pathological reports. We are
grateful to Dr M. M. Suzman and members of his unit for
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